Conference
289 A Canadian Cancer Trials Group phase IB study of durvalumab with or without tremelimumab + standard platinum-doublet chemotherapy in patients with advanced, incurable solid malignancies (IND.226)
Authors
Hao D; Juergens R; Laurie S; Mates M; Tehfe M; Bradbury P; Kollmannsberger C; Ellis P; Hilton J; Brown-Walker P
Volume
69
Publisher
Elsevier
Publication Date
December 2016
DOI
10.1016/s0959-8049(16)32882-9
Conference proceedings
European Journal of Cancer
ISSN
0959-8049